Kensuke Sakata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kensuke Sakata has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Natalia A. Trayanova
Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, Maryland, USA
6 shared publications - Carolyna Yamamoto
Johns Hopkins University
5 shared publications - Eugene G. Kholmovski
Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, Maryland, USA; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, USA
5 shared publications - Syed Yusuf Ali
Department of Biomedical Engineering and Medicine, Johns Hopkins University , Baltimore, MD
5 shared publications - Yazan Mohsen
Department of Biomedical Engineering Johns Hopkins University Baltimore Maryland USA
5 shared publications - Shane Loeffler
Alliance for Cardiovascular Diagnostic and Treatment Innovation Johns Hopkins University Baltimore Maryland USA
4 shared publications
Latest Publications
- 7 October 2026
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 288
Graph neural network for predicting reentrant drivers in atrial digital twins
- 7 October 2026
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 288
Graph neural network for predicting reentrant drivers in atrial digital twins
- Open Access
- 25 September 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (5) , e70461
Clinical Vulnerability Refines Rhythm‐Related Outcomes in Older Patients Undergoing Pulmonary Vein Isolation for Atrial Fibrillation: An Observational Cohort Study
Introduction: Chronological age is often considered when selecting patients for atrial fibrillation (AF) ablation, but age alone may not identify which older patients are most likely to require recurrent rhythm‐related care after pulmonary vein isolation (PVI). Methods: We conducted a single‐center observational study of consecutive patients undergoing PVI. The principal registry cohort assessed the same‐center recurrence‐related rhythm‐intervention endpoint, defined as the first post‐index repeat PVI or electrical cardioversion. A nested active 2022 cohort assessed broader actively ascertained recurrence. Age was analyzed as < 50, 50–74, and ≥ 75. An exploratory elderly vulnerability score assigned one point each for documented persistent AF, heart failure, chronic kidney disease, and valve disease/surgery. Results: The registry cohort included 2559 patients and 580 same‐center rhythm‐intervention events. Event rates increased across age groups: 14.2% in patients aged < 50, 20.8% in those aged 50–74, and 29.8% in those aged ≥ 75. Age ≥ 75 was independently associated with higher risk versus age 50–74 in adjusted registry Cox analysis, HR: 1.35, 95% CI: 1.12–1.64, p = 0.002, after 90‐day blanking, HR: 1.37, 95% CI: 1.12–1.69, p = 0.002, and in the active cohort, HR: 1.46, 95% CI: 1.01–2.11, p = 0.042. Elderly Score 0 patients were not significantly different from patients aged 50–74 in registry analysis, aHR: 1.13, 95% CI: 0.79–1.63, p = 0.5, or active analysis, aHR: 1.01, 95% CI: 0.49–2.09, p = 0.975, whereas Score ≥ 2 identified higher event burden in both the registry cohort, aHR: 1.85, 95% CI: 1.45–2.35, p < 0.001, and active cohort, aHR: 1.95, 95% CI: 1.23–3.12, p = 0.005. Conclusion: Age ≥ 75 was associated with a higher rate of same‐center recurrence‐related rhythm interventions after PVI, but the risk varied substantially. Clinical vulnerability, not chronological age alone, may better inform counseling and selection of older patients.
- 25 September 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (5) , e70461
Open AccessClinical Vulnerability Refines Rhythm‐Related Outcomes in Older Patients Undergoing Pulmonary Vein Isolation for Atrial Fibrillation: An Observational Cohort Study
Introduction: Chronological age is often considered when selecting patients for atrial fibrillation (AF) ablation, but age alone may not identify which older patients are most likely to require recurrent rhythm‐related care after pulmonary vein isolation (PVI). Methods: We conducted a single‐center observational study of consecutive patients undergoing PVI. The principal registry cohort assessed the same‐center recurrence‐related rhythm‐intervention endpoint, defined as the first post‐index repeat PVI or electrical cardioversion. A nested active 2022 cohort assessed broader actively ascertained recurrence. Age was analyzed as < 50, 50–74, and ≥ 75. An exploratory elderly vulnerability score assigned one point each for documented persistent AF, heart failure, chronic kidney disease, and valve disease/surgery. Results: The registry cohort included 2559 patients and 580 same‐center rhythm‐intervention events. Event rates increased across age groups: 14.2% in patients aged < 50, 20.8% in those aged 50–74, and 29.8% in those aged ≥ 75. Age ≥ 75 was independently associated with higher risk versus age 50–74 in adjusted registry Cox analysis, HR: 1.35, 95% CI: 1.12–1.64, p = 0.002, after 90‐day blanking, HR: 1.37, 95% CI: 1.12–1.69, p = 0.002, and in the active cohort, HR: 1.46, 95% CI: 1.01–2.11, p = 0.042. Elderly Score 0 patients were not significantly different from patients aged 50–74 in registry analysis, aHR: 1.13, 95% CI: 0.79–1.63, p = 0.5, or active analysis, aHR: 1.01, 95% CI: 0.49–2.09, p = 0.975, whereas Score ≥ 2 identified higher event burden in both the registry cohort, aHR: 1.85, 95% CI: 1.45–2.35, p < 0.001, and active cohort, aHR: 1.95, 95% CI: 1.23–3.12, p = 0.005. Conclusion: Age ≥ 75 was associated with a higher rate of same‐center recurrence‐related rhythm interventions after PVI, but the risk varied substantially. Clinical vulnerability, not chronological age alone, may better inform counseling and selection of older patients.
- 3 August 2026
- Published by Wiley in The Journal of Physiology
Transmural heterogeneity in 3D fibrosis distribution is associated with endo‐epicardial electrical dyssynchrony in persistent atrial fibrillation
Despite the established role of endo‐epicardial dissociation in the substrate of persistent atrial fibrillation (PsAF), the underlying mechanisms within the 3D atrial wall that lead to this phenomenon are not fully understood. Using personalized digital twin (DT) technology, we investigated the association between 3D transmurally heterogenous fibrosis architecture and endo‐epicardial dissociation in PsAF. LGE‐MRI scans from 21 PsAF patients were used to generate bi‐atrial DTs. Following virtual induction of reentry using programmed stimulation, a comparative analysis of the electrophysiological and structural properties of reentry‐sustaining regions (RRs, n = 91) against controls (non‐RRs, n = 73) was performed. RRs exhibited significantly greater endo‐epicardial dissociation compared to non‐RRs, evidenced by larger differences in median transmembrane potential (60.1 vs . 4.1 mV, P < 0.001) and local activation times (55 vs . 14.9 ms, P < 0.001). Lower dice similarity coefficient (DSC) was observed in RRs compared with non‐RRs (median 0.731 (IQR 0.660–0.812) versus 0.880 (IQR 0.642–0.971), respectively; P = 0.0009). In multivariable logistic regression, fibrosis percentage, transmembrane voltage difference, and DSC were independently associated with RR status, whereas LAT difference was not. Our findings reveal that 3D transmurally heterogeneous fibrosis architecture is associated with endo‐epicardial electrical dissociation in PsAF, with increased dissociation observed in regions harbouring reentrant circuits. Our findings advance the mechanistic understanding of PsAF arrhythmogenesis and provide a rationale for developing novel mapping and ablation strategies that account for the transmural complexity of the atrial substrate. image Key points: Persistent atrial fibrillation (PsAF) remains a significant clinical challenge, often marked by high rates of post‐ablation recurrence. While endo‐epicardial dissociation is a known factor in the PsAF substrate, the underlying mechanisms within the 3D atrial wall that lead to this phenomenon remain incompletely understood. In this study, we utilized personalized digital twin technology derived from LGE‐MRI scans of 21 patients to investigate the association between transmurally heterogeneous fibrosis and endo‐epi electrical dissociation. Our findings reveal that 3D transmurally heterogeneous fibrosis architecture is associated with endo‐epicardial electrical dissociation in PsAF. In multivariable analysis, fibrosis percentage, transmembrane voltage difference, and DSC were independently associated with reentrant activity. This work not only advances the mechanistic understanding of PsAF arrhythmogenesis but also suggests that successful clinical ablation strategies must account for the full 3D complexity of the atrial wall to target hidden intramural and epicardial pathways.
- 3 August 2026
- Published by Wiley in The Journal of Physiology
Transmural heterogeneity in 3D fibrosis distribution is associated with endo‐epicardial electrical dyssynchrony in persistent atrial fibrillation
Despite the established role of endo‐epicardial dissociation in the substrate of persistent atrial fibrillation (PsAF), the underlying mechanisms within the 3D atrial wall that lead to this phenomenon are not fully understood. Using personalized digital twin (DT) technology, we investigated the association between 3D transmurally heterogenous fibrosis architecture and endo‐epicardial dissociation in PsAF. LGE‐MRI scans from 21 PsAF patients were used to generate bi‐atrial DTs. Following virtual induction of reentry using programmed stimulation, a comparative analysis of the electrophysiological and structural properties of reentry‐sustaining regions (RRs, n = 91) against controls (non‐RRs, n = 73) was performed. RRs exhibited significantly greater endo‐epicardial dissociation compared to non‐RRs, evidenced by larger differences in median transmembrane potential (60.1 vs . 4.1 mV, P < 0.001) and local activation times (55 vs . 14.9 ms, P < 0.001). Lower dice similarity coefficient (DSC) was observed in RRs compared with non‐RRs (median 0.731 (IQR 0.660–0.812) versus 0.880 (IQR 0.642–0.971), respectively; P = 0.0009). In multivariable logistic regression, fibrosis percentage, transmembrane voltage difference, and DSC were independently associated with RR status, whereas LAT difference was not. Our findings reveal that 3D transmurally heterogeneous fibrosis architecture is associated with endo‐epicardial electrical dissociation in PsAF, with increased dissociation observed in regions harbouring reentrant circuits. Our findings advance the mechanistic understanding of PsAF arrhythmogenesis and provide a rationale for developing novel mapping and ablation strategies that account for the transmural complexity of the atrial substrate. image Key points: Persistent atrial fibrillation (PsAF) remains a significant clinical challenge, often marked by high rates of post‐ablation recurrence. While endo‐epicardial dissociation is a known factor in the PsAF substrate, the underlying mechanisms within the 3D atrial wall that lead to this phenomenon remain incompletely understood. In this study, we utilized personalized digital twin technology derived from LGE‐MRI scans of 21 patients to investigate the association between transmurally heterogeneous fibrosis and endo‐epi electrical dissociation. Our findings reveal that 3D transmurally heterogeneous fibrosis architecture is associated with endo‐epicardial electrical dissociation in PsAF. In multivariable analysis, fibrosis percentage, transmembrane voltage difference, and DSC were independently associated with reentrant activity. This work not only advances the mechanistic understanding of PsAF arrhythmogenesis but also suggests that successful clinical ablation strategies must account for the full 3D complexity of the atrial wall to target hidden intramural and epicardial pathways.
- Open Access
- 30 June 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (4)
Documented Obstructive Sleep Apnea, Cardiometabolic Phenotype, and Rhythm‐Related Outcomes After Atrial Fibrillation Ablation: An Observational Cohort Study
Background: Obstructive sleep apnea syndrome (OSAS) is common in atrial fibrillation (AF) and may influence AF phenotype and post‐ablation recurrence. We aimed to determine whether documented OSAS identifies a distinct clinical phenotype and whether it is associated with post‐ablation rhythm‐related outcomes. Methods: We performed a single‐center observational study with two overlapping cohorts. The principal registry cohort comprised 2559 patients with first AF ablation with pulmonary vein isolation (PVI) treated between November/2021 and July/2025. Its primary endpoint was the same‐center rhythm‐intervention endpoint, defined as the first post‐index repeat PVI or electrical cardioversion at the study center. A 7‐day Holter was scheduled 90 days after ablation. The nested active 2022 cohort comprised 666 AF/PVI patients. Results: Documented OSAS was present in 268 of 2559 registry patients, 10.5%, and in 66 of 652 patients with known OSAS status in the active subset, 10.1%. Documented OSAS was associated with higher BMI, more obesity, hypertension, diabetes, persistent AF, higher triglycerides and liver enzymes, and lower HDL cholesterol. In the registry cohort, the same‐center rhythm‐intervention endpoint occurred in 59/268 patients with documented OSAS (22.0%) and 521/2291 without documented OSAS (22.7%; p = 0.788). Documented OSAS was not associated with the registry endpoint after adjustment (OR: 0.87, 95% CI: 0.63–1.21; p = 0.411). In the active 2022 cohort, recurrence occurred in 16/32 patients with documented OSAS (50.0%) and 167/302 without documented OSAS (55.3%; p = 0.581). Adjusted Cox analysis also showed no independent documented OSAS (HR: 1.08, 95% CI: 0.61–1.94; p = 0.786). Conclusion: Documented OSAS identified an adverse cardiometabolic AF ablation phenotype but was not independently associated with same‐center rhythm interventions.
- 30 June 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (4)
Open AccessDocumented Obstructive Sleep Apnea, Cardiometabolic Phenotype, and Rhythm‐Related Outcomes After Atrial Fibrillation Ablation: An Observational Cohort Study
Background: Obstructive sleep apnea syndrome (OSAS) is common in atrial fibrillation (AF) and may influence AF phenotype and post‐ablation recurrence. We aimed to determine whether documented OSAS identifies a distinct clinical phenotype and whether it is associated with post‐ablation rhythm‐related outcomes. Methods: We performed a single‐center observational study with two overlapping cohorts. The principal registry cohort comprised 2559 patients with first AF ablation with pulmonary vein isolation (PVI) treated between November/2021 and July/2025. Its primary endpoint was the same‐center rhythm‐intervention endpoint, defined as the first post‐index repeat PVI or electrical cardioversion at the study center. A 7‐day Holter was scheduled 90 days after ablation. The nested active 2022 cohort comprised 666 AF/PVI patients. Results: Documented OSAS was present in 268 of 2559 registry patients, 10.5%, and in 66 of 652 patients with known OSAS status in the active subset, 10.1%. Documented OSAS was associated with higher BMI, more obesity, hypertension, diabetes, persistent AF, higher triglycerides and liver enzymes, and lower HDL cholesterol. In the registry cohort, the same‐center rhythm‐intervention endpoint occurred in 59/268 patients with documented OSAS (22.0%) and 521/2291 without documented OSAS (22.7%; p = 0.788). Documented OSAS was not associated with the registry endpoint after adjustment (OR: 0.87, 95% CI: 0.63–1.21; p = 0.411). In the active 2022 cohort, recurrence occurred in 16/32 patients with documented OSAS (50.0%) and 167/302 without documented OSAS (55.3%; p = 0.581). Adjusted Cox analysis also showed no independent documented OSAS (HR: 1.08, 95% CI: 0.61–1.94; p = 0.786). Conclusion: Documented OSAS identified an adverse cardiometabolic AF ablation phenotype but was not independently associated with same‐center rhythm interventions.
- Open Access
- 27 March 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (4)
Relationships between three-dimensional fibrosis distribution, atrial adiposity, and voltage abnormalities associated with persistent atrial fibrillation
Persistent atrial fibrillation (PsAF) is often refractory to pulmonary vein isolation, a well-established AF treatment, owing to the fibrosis-remodeled substrates sustaining reentries. Three-dimensional fibrosis distribution and atrial adiposity have been found to be essential contributors to PsAF arrhythmogenesis. We aimed to utilize late gadolinium enhancement (LGE)-MRI-derived personalized heart digital twins (DTs)—a recent promising tool for non-invasively assessing patient arrhythmogenesis—as well as contrast-enhanced cardiac computed tomography (CCT) images and electroanatomic maps (EAMs) to investigate relationships between fibrosis distribution, including endo–epi differences, adiposity infiltration, and electrophysiological abnormalities, and their influence on PsAF arrhythmogenic substrate. DTs incorporating fibrosis distribution were generated from consecutive PsAF patients’ LGE-MRIs. Using rapid pacing, potential locations attracting reentries (LRs) were identified in DTs. CCTs were used to segment adipose tissue within pericardial sac and evaluate the distance from endocardial surface to closest adipose tissue (DEnCA). Bipolar- and unipolar-low-voltage area fractions (LVFs) were extracted from EAMs. Volumetric fibrosis fraction (FF) and surface FF on endocardial and epicardial surfaces at LRs and non-LRs were analyzed in relation to DEnCA and LVF. In 22 patients, adipose tissue volume correlated with BMI and CHA2DS2-VASc and, together with atrial-FF, predicted number of LRs. At LRs and non-LRs, while volumetric-FF was the sole determinant of LR classification, volumetric-FF correlated with endocardium-predominant fibrosis and bipolar-LVF. Endocardium-predominant fibrosis was independently linked to DEnCA. This study highlights the complex interactions between structural features, such as three-dimensional fibrosis distribution and atrial adiposity infiltration, electrophysiological features, and PsAF arrhythmogenesis.
- 27 March 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (4)
Open AccessRelationships between three-dimensional fibrosis distribution, atrial adiposity, and voltage abnormalities associated with persistent atrial fibrillation
Persistent atrial fibrillation (PsAF) is often refractory to pulmonary vein isolation, a well-established AF treatment, owing to the fibrosis-remodeled substrates sustaining reentries. Three-dimensional fibrosis distribution and atrial adiposity have been found to be essential contributors to PsAF arrhythmogenesis. We aimed to utilize late gadolinium enhancement (LGE)-MRI-derived personalized heart digital twins (DTs)—a recent promising tool for non-invasively assessing patient arrhythmogenesis—as well as contrast-enhanced cardiac computed tomography (CCT) images and electroanatomic maps (EAMs) to investigate relationships between fibrosis distribution, including endo–epi differences, adiposity infiltration, and electrophysiological abnormalities, and their influence on PsAF arrhythmogenic substrate. DTs incorporating fibrosis distribution were generated from consecutive PsAF patients’ LGE-MRIs. Using rapid pacing, potential locations attracting reentries (LRs) were identified in DTs. CCTs were used to segment adipose tissue within pericardial sac and evaluate the distance from endocardial surface to closest adipose tissue (DEnCA). Bipolar- and unipolar-low-voltage area fractions (LVFs) were extracted from EAMs. Volumetric fibrosis fraction (FF) and surface FF on endocardial and epicardial surfaces at LRs and non-LRs were analyzed in relation to DEnCA and LVF. In 22 patients, adipose tissue volume correlated with BMI and CHA2DS2-VASc and, together with atrial-FF, predicted number of LRs. At LRs and non-LRs, while volumetric-FF was the sole determinant of LR classification, volumetric-FF correlated with endocardium-predominant fibrosis and bipolar-LVF. Endocardium-predominant fibrosis was independently linked to DEnCA. This study highlights the complex interactions between structural features, such as three-dimensional fibrosis distribution and atrial adiposity infiltration, electrophysiological features, and PsAF arrhythmogenesis.
- 19 January 2026
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 122 (4) , 480-491
Arrhythmogenic substrates in atrial fibrillation and the role of ablation lesions: a longitudinal biatrial digital twin study
Aims: Arrhythmogenic fibrotic substrates facilitate reentrant activity in the atria, contributing to the perpetuation of atrial fibrillation (AF). Catheter ablation may disrupt existing reentrant pathways but can also create new ones. This longitudinal study aimed to assess whether post-ablation AF recurrence is associated with incomplete elimination of native arrhythmogenic substrates or emergence of new arrhythmogenic substrates created by ablation lesions, addressing important questions in current AF management: why some patients experience recurrence post-ablation while others do not, and whether ablation lesions themselves contribute to post-ablation arrhythmogenesis. Methods and results: Biatrial digital twins (DTs) derived from pre- and post-ablation contrast-enhanced magnetic resonance imaging were used to evaluate the arrhythmogenic propensity of the fibrotic substrate—quantified by potential reentry-sites (PRs) and a vulnerability index (VI) reflecting reentry inducibility. Pre- and post-ablation DT pairs were generated for 11 patients who experienced AF recurrence (R-DTs) and 11 who did not (N-DTs). In total, 58 pre-ablation PRs and 32 post-ablation PRs were detected, with a nearly even distribution of PRs between the left atrium (LA) and right atrium (RA) both pre- and post-ablation. Pre-ablation VI was similar between N-DTs and R-DTs; however, post-ablation VI was significantly higher in R-DTs (P = 0.015). N-DTs exhibited a marked reduction in PRs following ablation, whereas R-DTs did not (P = 0.017). Both groups had few residual PRs from pre- to post-ablation, but R-DTs had many newly emergent PRs. In R-DTs, emergent PRs in the RA were accompanied by a post-ablation increase in RA fibrotic burden. In the LA, where lesions were delivered, all post-ablation reentries anchored around ablation-induced scar (ScAReentries). ScAReentries were significantly more inducible than those occurring within fibrotic substrate and were nearly three times more prevalent in R-DTs, accounting for the elevated post-ablation VI. Conclusion: In DTs, emergent PRs in both atria underlie AF recurrence post-ablation, with ablation itself creating some PRs of high arrhythmogenic propensity.
- 19 January 2026
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 122 (4) , 480-491
Arrhythmogenic substrates in atrial fibrillation and the role of ablation lesions: a longitudinal biatrial digital twin study
Aims: Arrhythmogenic fibrotic substrates facilitate reentrant activity in the atria, contributing to the perpetuation of atrial fibrillation (AF). Catheter ablation may disrupt existing reentrant pathways but can also create new ones. This longitudinal study aimed to assess whether post-ablation AF recurrence is associated with incomplete elimination of native arrhythmogenic substrates or emergence of new arrhythmogenic substrates created by ablation lesions, addressing important questions in current AF management: why some patients experience recurrence post-ablation while others do not, and whether ablation lesions themselves contribute to post-ablation arrhythmogenesis. Methods and results: Biatrial digital twins (DTs) derived from pre- and post-ablation contrast-enhanced magnetic resonance imaging were used to evaluate the arrhythmogenic propensity of the fibrotic substrate—quantified by potential reentry-sites (PRs) and a vulnerability index (VI) reflecting reentry inducibility. Pre- and post-ablation DT pairs were generated for 11 patients who experienced AF recurrence (R-DTs) and 11 who did not (N-DTs). In total, 58 pre-ablation PRs and 32 post-ablation PRs were detected, with a nearly even distribution of PRs between the left atrium (LA) and right atrium (RA) both pre- and post-ablation. Pre-ablation VI was similar between N-DTs and R-DTs; however, post-ablation VI was significantly higher in R-DTs (P = 0.015). N-DTs exhibited a marked reduction in PRs following ablation, whereas R-DTs did not (P = 0.017). Both groups had few residual PRs from pre- to post-ablation, but R-DTs had many newly emergent PRs. In R-DTs, emergent PRs in the RA were accompanied by a post-ablation increase in RA fibrotic burden. In the LA, where lesions were delivered, all post-ablation reentries anchored around ablation-induced scar (ScAReentries). ScAReentries were significantly more inducible than those occurring within fibrotic substrate and were nearly three times more prevalent in R-DTs, accounting for the elevated post-ablation VI. Conclusion: In DTs, emergent PRs in both atria underlie AF recurrence post-ablation, with ablation itself creating some PRs of high arrhythmogenic propensity.
- 29 April 2025
- Published by Springer Nature
- p. 345-356
SegBAW-Net: Segmentation of Bi-Atria and Wall Network Offering Valuable Insights into Challenge Data
- 29 April 2025
- Published by Springer Nature
- p. 345-356
SegBAW-Net: Segmentation of Bi-Atria and Wall Network Offering Valuable Insights into Challenge Data
- Open Access
- 18 June 2024
- Published by Springer Nature in Nature Cardiovascular Research
- Vol. 3 (7) , 857-868
Assessing the arrhythmogenic propensity of fibrotic substrate using digital twins to inform a mechanisms-based atrial fibrillation ablation strategy
Atrial fibrillation (AF), the most common heart rhythm disorder, may cause stroke and heart failure. For patients with persistent AF with fibrosis proliferation, the standard AF treatment—pulmonary vein isolation—has poor outcomes, necessitating redo procedures, owing to insufficient understanding of what constitutes good targets in fibrotic substrates. Here we present a prospective clinical and personalized digital twin study that characterizes the arrhythmogenic properties of persistent AF substrates and uncovers locations possessing rotor-attracting capabilities. Among these, a portion needs to be ablated to render the substrate not inducible for rotors, but the rest (37%) lose rotor-attracting capabilities when another location is ablated. Leveraging digital twin mechanistic insights, we suggest ablation targets that eliminate arrhythmia propensity with minimum lesions while also minimizing the risk of iatrogenic tachycardia and AF recurrence. Our findings provide further evidence regarding the appropriate substrate ablation targets in persistent AF, opening the door for effective strategies to mitigate patients’ AF burden.
- 18 June 2024
- Published by Springer Nature in Nature Cardiovascular Research
- Vol. 3 (7) , 857-868
Open AccessAssessing the arrhythmogenic propensity of fibrotic substrate using digital twins to inform a mechanisms-based atrial fibrillation ablation strategy
Atrial fibrillation (AF), the most common heart rhythm disorder, may cause stroke and heart failure. For patients with persistent AF with fibrosis proliferation, the standard AF treatment—pulmonary vein isolation—has poor outcomes, necessitating redo procedures, owing to insufficient understanding of what constitutes good targets in fibrotic substrates. Here we present a prospective clinical and personalized digital twin study that characterizes the arrhythmogenic properties of persistent AF substrates and uncovers locations possessing rotor-attracting capabilities. Among these, a portion needs to be ablated to render the substrate not inducible for rotors, but the rest (37%) lose rotor-attracting capabilities when another location is ablated. Leveraging digital twin mechanistic insights, we suggest ablation targets that eliminate arrhythmia propensity with minimum lesions while also minimizing the risk of iatrogenic tachycardia and AF recurrence. Our findings provide further evidence regarding the appropriate substrate ablation targets in persistent AF, opening the door for effective strategies to mitigate patients’ AF burden.
- Open Access
- 3 May 2023
- Published by Wiley in Journal of Arrhythmia
- Vol. 39 (3) , 315-326
The spatiotemporal electrogram dispersion ablation targeting rotors is more effective for elderly patients than non‐elderly population
Background: Modulating atrial fibrillation (AF) drivers has been proposed as one of the effective ablation strategies for non‐paroxysmal AF (non‐PAF). However, the optimal non‐PAF ablation strategy is still under debate because the exact mechanisms of AF persistence including focal activity and/or rotational activity, are not well‐understood. Recently, spatiotemporal electrogram dispersion (STED) assumed to indicate rotors in the form of rotational activity is proposed as an effective target for non‐PAF ablation. We aimed to clarify the effectiveness of STED ablation for modulating AF drivers.Methods: STED ablation plus pulmonary vein isolation was applied in 161 consecutive non‐PAF patients not undergoing previous ablation. STED areas within the entire left and right atria were identified and ablated during AF. After the procedures, the STED ablation's acute and long‐term outcomes were investigated.Results: (1) Despite a more effective acute outcome of the STED ablation for both AF termination and non‐inducibility of atrial tachyarrhythmias (ATAs), Kaplan–Meier curves showed that the 24‐month freedom ratio from ATAs was 49%, which resulted from the higher recurrence ratio of atrial tachycardia (AT) rather than AF. (2) A multivariate analysis showed that the determinant of ATA recurrences was only a non‐elderly age, not long‐standing persistent AF, and an enlarged left atrium, which were conventionally considered as key factors.Conclusions: STED ablation targeting rotors was effective in elderly non‐PAF patients. Therefore, the main mechanism of AF persistency and the component of the fibrillatory conduction might vary between elders and non‐elders. However, we should be careful about post‐ablation ATs following substrate modification.
- 3 May 2023
- Published by Wiley in Journal of Arrhythmia
- Vol. 39 (3) , 315-326
Open AccessThe spatiotemporal electrogram dispersion ablation targeting rotors is more effective for elderly patients than non‐elderly population
Background: Modulating atrial fibrillation (AF) drivers has been proposed as one of the effective ablation strategies for non‐paroxysmal AF (non‐PAF). However, the optimal non‐PAF ablation strategy is still under debate because the exact mechanisms of AF persistence including focal activity and/or rotational activity, are not well‐understood. Recently, spatiotemporal electrogram dispersion (STED) assumed to indicate rotors in the form of rotational activity is proposed as an effective target for non‐PAF ablation. We aimed to clarify the effectiveness of STED ablation for modulating AF drivers.Methods: STED ablation plus pulmonary vein isolation was applied in 161 consecutive non‐PAF patients not undergoing previous ablation. STED areas within the entire left and right atria were identified and ablated during AF. After the procedures, the STED ablation's acute and long‐term outcomes were investigated.Results: (1) Despite a more effective acute outcome of the STED ablation for both AF termination and non‐inducibility of atrial tachyarrhythmias (ATAs), Kaplan–Meier curves showed that the 24‐month freedom ratio from ATAs was 49%, which resulted from the higher recurrence ratio of atrial tachycardia (AT) rather than AF. (2) A multivariate analysis showed that the determinant of ATA recurrences was only a non‐elderly age, not long‐standing persistent AF, and an enlarged left atrium, which were conventionally considered as key factors.Conclusions: STED ablation targeting rotors was effective in elderly non‐PAF patients. Therefore, the main mechanism of AF persistency and the component of the fibrillatory conduction might vary between elders and non‐elders. However, we should be careful about post‐ablation ATs following substrate modification.